Modulatory effect of glial fibrillary acidic protein (GFAP) levels on the association between plasma p ‐tau217 levels and cognitive decline in older adults

Abstract

Background: Recent studies demonstrate an association between glial fibrillary acidic protein (GFAP) levels and post‐mortem tau pathology and highlighted its role as a link between amyloid and tau pathology in Alzheimer's disease (AD) [Sánchez‐Juan, Pascual, et al., Brain 147.5 (2024): 1667‐1679.].